Arnold Lippa serves as Executive at CORTEX PHARMACEUTICALS INC/DE/, where they oversee executive responsibilities. Since joining the company, Arnold Lippa has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 22, 2020 involved gifting 4,500,000 shares valued at $0.
Arnold Lippa currently holds 598 shares of CORTEX PHARMACEUTICALS INC/DE/ (CORX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Arnold Lippa has been a net neutral trader of CORX stock. They have purchased $0 and sold $0 worth of shares.
Arnold Lippa's most recent insider trade was on Mar 22, 2020, when they sold 4,500,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 12, 2018 | RSPI | $0 | Purchase | 47,620 | $N/A | Discretionary |
| Sep 12, 2018 | RSPI | $0 | Gift | 47,620 | $N/A | Discretionary |
| Apr 14, 2014 | CORX | $0 | Award | 15,000,000 | $N/A | Discretionary |